NL-OMON53183RecruitingNot Applicable
Prospective study to evaluate trained immunity in kidney transplantation - PROTEKT
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Kidney transplant recipient
- •Age 18 - 80 years
Exclusion Criteria
- •No informed consent
- •Infection in the past four weeks
Investigators
Similar Trials
Recruiting
Phase 2
Exploratory study evaluating the potential of immune signature profiling for predicting response in patients with resectable Stage II, IIIA and select IIIB (T3N2 only) non-squamous Non-Small Cell Lung Cancer (NSCLC) to neoadjuvant ATEZOLIZUMAB plus Carboplatin/Nab PaclitaxelLung cancer2024-516590-75-00Universitaetsklinikum Heidelberg AöR, Universitaetsklinikum Heidelberg AöR20
Active, not recruiting
Phase 1
A study on the anti-inflammatory effects of azithromycin in tuberculosisPulmonary tuberculosisEUCTR2017-001929-40-NLniversity Medical Center Groningen24
Recruiting
Phase 2
A prospective, randomized pilot study of the immunomodulatory effects of azithromycin in adults with pulmonary tuberculosisTBTuberculosisNL-OMON47928niversitair Medisch Centrum Groningen24
Completed
Unknown
A study for evaluating the immune response by ingestion of fermented plant extractHealthy adultJPRN-UMIN000052021EP Mediate Co., Ltd.36
Completed
Not Applicable
A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females : a randomized, double blind, placebo-controlled, parallel-group trialJPRN-UMIN000024995TTC Co., Ltd.60
